With the Supreme Court maintaining a status quo of sorts with regard to the Patient Protection and Affordable Care Act last month, retail pharmacy operators are going to need to continually drive efficiencies into their businesses, McKesson chairman and CEO John Hammergren noted during the wholesaler's first-quarter conference call.
Safeway is looking to its recently launched Just for U loyalty program, which this month became available across all U.S. divisions, to help drive a positive sales story through the rest of the fiscal year.
Supervalu on Thursday announced a number of dramatic measures to stabilize its business — reduction in capital spending, suspension of the company's dividend, even the exploration of possible strategic alternatives — in conjunction with its declining first-quarter earnings results.
Canadian retail pharmacy operator the Jean Coutu Group posted big increases in sales and profits that stemmed in large part from its sale earlier this year of much of its stake in U.S. retail pharmacy chain Rite Aid.
Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention.
The Food and Drug Administration has approved a branded acne drug made by Ranbaxy Labs, the drug maker said. Ranbaxy announced the FDA approval of Absorica (isotretinoin), a drug for treating severe recalcitrant nodular acne.
Eye care supplements have become a big growth driver within eye care sets, and for good reason — baby boomers aren’t getting any younger and they plan to see their great grandkids play in the sandbox someday, so eye health is paramount.
Rite Aid maintained its same-store sales momentum, posting gains across front-end and pharmacy comparable sales for the sixth consecutive quarter: Overall same-store sales were up 2.5%, reflecting a 2.7% increase across the front-end and a 2.4% uptick across pharmacy, for the first quarter ended June 2.
The lackluster cough-cold season will necessitate a greater need for marketing and promotion next season, ProPhase Labs chairman and CEO Ted Karkus said on Thursday in announcing first-quarter results for the period ended March 31.
The recent loss of business from a key specialty pharmacy customer and the continued deluge of generic introductions will represent significant challenges for Cardinal Health in fiscal year 2013 as it approaches the year-end of its fiscal 2012, company executives told analysts during a conference call Thursday morning.
Colgate-Palmolive announced a boost in North America net sales for the first quarter and a gain in its share of the toothpaste market, thanks in part to the launch of Colgate Optic White and Colgate Sensitive Pro-Relief toothpastes, the company said Thursday.
Beauty company Revlon announced on Thursday first-quarter sales results, which benefited from higher net sales of Revlon color cosmetics and Revlon ColorSilk hair color, as well as the inclusion of sales from SinfulColors.